Why This Moderna Analyst Is Very Bullish
Shares of Moderna Inc (NASDAQ: MRNA) have lost almost 24% year to date.
While the prospects of the Covid-vaccine seem to be waning, data from the cancer vaccine is impressive, according to RBC Capital Markets.
